Holen Sie sich die Stockscreener-App
1.63
0.61%
-0.01
Handel nachbörslich:
1.66
0.03
+1.84%
Schlusskurs vom Vortag:
$1.64
Offen:
$1.68
24-Stunden-Volumen:
547.99K
Relative Volume:
1.41
Marktkapitalisierung:
$58.60M
Einnahmen:
$210.70K
Nettoeinkommen (Verlust:
$-21.37M
KGV:
-1.4818
EPS:
-1.1
Netto-Cashflow:
$-21.10M
1W Leistung:
-4.68%
1M Leistung:
-5.78%
6M Leistung:
-22.75%
1J Leistung:
+10.14%
1-Tages-Spanne:
$1.595
$1.6999
1-Wochen-Bereich:
$1.595
$1.78
52-Wochen-Spanne:
$1.36
$3.19
Gain Therapeutics Inc Stock (GANX) Company Profile
Firmenname
Gain Therapeutics Inc
Sektor
Branche
Telefon
(301) 500-1556
Adresse
4800 HAMPDEN LANE, BETHESDA
Vergleichen Sie GANX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.63 | 58.96M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-08-14 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-04-12 | Eingeleitet | BTIG Research | Buy |
| 2021-04-12 | Eingeleitet | Oppenheimer | Outperform |
Gain Therapeutics Inc Aktie (GANX) Neueste Nachrichten
Applying Elliott Wave Theory to Gain Therapeutics Inc.Weekly Stock Analysis & Short-Term High Return Ideas - newser.com
Published on: 2025-09-16 14:43:05 - خودرو بانک
Combining machine learning predictions for Gain Therapeutics Inc.July 2025 PostEarnings & Risk Controlled Stock Pick Alerts - newser.com
What institutional flow reveals about Gain Therapeutics Inc.Sell Signal & Expert Approved Trade Ideas - newser.com
Using fundamentals and technicals on Gain Therapeutics Inc.Earnings Miss & Real-Time Chart Breakout Alerts - newser.com
Is Gain Therapeutics Inc stock trending bullishMarket Activity Report & High Accuracy Trade Signal Alerts - خودرو بانک
Pullback Watch: Can Gain Therapeutics Inc stock double in the next yearWeekly Earnings Recap & Consistent Income Trade Ideas - خودرو بانک
Aug Final Week: Is Gain Therapeutics Inc stock forming a triangle pattern2025 Key Lessons & Safe Swing Trade Setups - خودرو بانک
Gains Recap: What drives Gain Therapeutics Inc.’s stock priceShort Setup & Weekly High Potential Alerts - خودرو بانک
Street Watch: Whats the beta of Gain Therapeutics Inc stockJuly 2025 WrapUp & Smart Swing Trading Techniques - خودرو بانک
Risk adjusted return profile for Gain Therapeutics Inc. analyzedQuarterly Earnings Report & Consistent Profit Focused Trading Strategies - newser.com
Is Gain Therapeutics Inc. forming a bottoming baseBreakout Watch & Safe Capital Investment Plans - newser.com
Analyzing net buyer seller activity in Gain Therapeutics Inc.Earnings Miss & Smart Allocation Stock Reports - newser.com
How to integrate Gain Therapeutics Inc. into portfolio analysis tools2025 Top Decliners & Growth Focused Stock Reports - newser.com
Can a trend reversal in Gain Therapeutics Inc. lead to recoveryJuly 2025 Analyst Calls & Verified Momentum Stock Ideas - newser.com
Real time breakdown of Gain Therapeutics Inc. stock performancePortfolio Risk Summary & Growth Focused Entry Point Reports - newser.com
What moving averages say about Gain Therapeutics Inc.July 2025 Retail & Smart Allocation Stock Tips - newser.com
Custom strategy builders for tracking Gain Therapeutics Inc.Price Action & Stepwise Entry/Exit Trade Alerts - newser.com
Does Gain Therapeutics Inc. show high probability of reboundMarket Trend Review & Stepwise Trade Signal Implementation - newser.com
Gain Therapeutics' (GANX) Buy Rating Reiterated at BTIG Research - MarketBeat
Forecasting Gain Therapeutics Inc. price range with options dataJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
How to use Fibonacci retracement on Gain Therapeutics Inc.July 2025 Market Mood & Reliable Entry Point Alerts - Newser
Live market analysis of Gain Therapeutics Inc.Trade Analysis Summary & Short-Term Trading Alerts - Newser
Historical volatility pattern of Gain Therapeutics Inc. visualizedMarket Growth Report & Safe Capital Growth Trade Ideas - Newser
Is Gain Therapeutics Inc. showing signs of accumulationEarnings Risk Report & Reliable Volume Spike Alerts - Newser
Custom watchlist performance reports with Gain Therapeutics Inc.Weekly Market Outlook & Weekly Stock Performance Updates - Newser
Is this a good reentry point in Gain Therapeutics Inc.July 2025 Trade Ideas & Entry Point Confirmation Signals - Newser
Technical signs of recovery in Gain Therapeutics Inc.Earnings Risk Report & Precise Trade Entry Recommendations - Newser
Using Ichimoku Cloud for Gain Therapeutics Inc. technicals2025 Dividend Review & Community Driven Trade Alerts - Newser
Order flow analysis tools used on Gain Therapeutics Inc.Weekly Trade Recap & Fast Entry Momentum Trade Alerts - Newser
Best data tools to analyze Gain Therapeutics Inc. stockMarket Growth Review & Weekly Return Optimization Alerts - Newser
Finanzdaten der Gain Therapeutics Inc-Aktie (GANX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
1.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):